null

SMILES: Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1

InChI Key: InChIKey=PXDWETVKDHRZFI-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 315001   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Orexin/Hypocretin receptor type 1 (Rattus norvegicus (Rat))	BDBM315001 (((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicy...) Show SMILES Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| Show InChI InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description Human Embryonic Kidney 293 cells (HEK293) stably expressing rat orexin 1 receptor (Genebank accession number NM_001525) or Chinese ovary cells (CHO) ...				US Patent US10183953 (2019) BindingDB Entry DOI: 10.7270/Q2Z60R5Q
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Rattus norvegicus (Rat))	BDBM315001 (((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicy...) Show SMILES Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| Show InChI InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description Human Embryonic Kidney 293 cells (HEK293) stably expressing rat orexin 1 receptor (Genebank accession number NM_001525) or Chinese ovary cells (CHO) ...				US Patent US9611277 (2017) BindingDB Entry DOI: 10.7270/Q24B33D2
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human))	BDBM315001 (((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicy...) Show SMILES Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| Show InChI InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description HEK293 stably expressing human orexin 2 receptor (Genebank accession number NM_001526) were grown to confluency in DMEM (Hyclone, cat # SH30022), 10%...				US Patent US9611277 (2017) BindingDB Entry DOI: 10.7270/Q24B33D2
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human))	BDBM315001 (((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicy...) Show SMILES Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| Show InChI InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description CHO cells stably transfected with the human orexin 1 receptor (Genebank accession number NM_001526) were grown to confluency in DMEM/F12, 10% FBS, 1×...				US Patent US10183953 (2019) BindingDB Entry DOI: 10.7270/Q2Z60R5Q
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM315001 (((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicy...) Show SMILES Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| Show InChI InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	218	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description HEK293 stably expressing human orexin 2 receptor (Genebank accession number NM_001526) were grown to confluency in DMEM (Hyclone, cat # SH30022), 10%...				US Patent US9611277 (2017) BindingDB Entry DOI: 10.7270/Q24B33D2
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM315001 (((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicy...) Show SMILES Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| Show InChI InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	218	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description PFSK-1 cells endogenously expressing the human orexin 2 receptor were grown to confluency in RPMI1640 (Hyclone, cat #30027.02), 10% FBS, 1× pen-strep...				US Patent US10183953 (2019) BindingDB Entry DOI: 10.7270/Q2Z60R5Q
					More data for this Ligand-Target Pair